Author:
Liu Kathy Y,Schneider Lon S,Howard Robert
Subject
Biological Psychiatry,Psychiatry and Mental health
Reference27 articles.
1. Questions EMERGE as Biogen claims aducanumab turnaround;Howard;Nat Rev Neurol,2019
2. A resurrection of aducanumab for Alzheimer's disease;Schneider;Lancet Neurol,2020
3. Failure to demonstrate efficacy of aducanumab: an analysis of the EMERGE and ENGAGE trials as reported by Biogen, December 2019;Knopman;Alzheimers Dement,2020
4. Department of Health and Human Services, Public Health Service, Food and Drug Administration. US Food and Drug Administration Peripheral and Central Nervous System Drugs Advisory Committee meeting; Rockville, MD, USA; July 7, 1989.
5. The ASA statement on p-values: context, process, and purpose;Wasserstein;Am Stat,2016
Cited by
74 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献